Logo
LUMI PRO Lips – Lip Booster 1.1ml

LUMI PRO Lips – Lip Booster 1.1ml

LUMI-PRO

Injectable skin booster
  • Marketed in the UK and EU as a professional Use non Cross Linked hyaluronic acid lip skin booster via regulated aesthetic wholesalers.
  • Manufactured under medical Aesthetic and cosmetic injectable quality systems (e.g. ISO 13485) appropriate for HA Based injectable devices; practitioners should verify exact CE/UKCA device marking and classification on packaging and in the technical file.
  • Use restricted to trained healthcare/aesthetic professionals in accordance with national regulations governing injectable hyaluronic acid skin boosters and related medical devices.
  • Distributors emphasise that LUMI PRO Lips is a skin booster (not a traditional dermal filler), aligning with current regulatory and clinical positioning of non Cross Linked HA injectables for skin quality.
Non-cross-linked hyaluronic acid lip skin booster

Description

LUMI-PRO Lips – Lip Booster 1.1ml is a first-in-market injectable skin booster created specifically for delicate lip tissue. Unlike traditional lip fillers, it is formulated as a non-cross-linked hyaluronic acid (HA) booster that enhances hydration, smoothness and natural lip definition without heavy volumisation. Each 1.1 ml pre-filled syringe contains 22 mg of pure, non-cross-linked HA, providing intense moisture and subtle, gentle volume. The treatment is designed to refine and perfect the lips’ existing shape, give a soft, natural-looking plump to untreated lips and optimise the appearance of lips that already contain dermal filler. Regular treatments throughout the year help maintain soft, supple, youthful-looking lips with improved texture, gloss and comfort.

Bnefits

  • First-ever injectable skin booster developed specifically for the lip tissue, rather than a traditional lip filler.
  • Contains 22 mg of pure, non-cross-linked hyaluronic acid per 1.1 ml syringe for deep hydration and gentle volume.
  • Enhances existing lip shape, maximising previous filler results and refining contours without an over-filled look.
  • Provides a natural-looking plump to untreated lips, improving softness and subtle fullness.
  • Intensely hydrates and smooths lip tissue, helping to reduce dryness, roughness and fine radial lip lines.
  • Improves overall lip texture and surface quality, giving a healthy, glossy, revitalised appearance.
  • Designed to work alongside all dermal filler brands as a complementary booster rather than a replacement.
  • Non-cross-linked HA means a softer, more diffused effect focused on lip health and quality, not rigid structure.
  • Can be repeated periodically across the year, similar to facial skin boosters, to maintain optimal lip condition.
  • Ideal for patients who want fresher, more youthful lips without committing to significant structural augmentation.

Indications

  • Dry, dehydrated or chapped lips lacking moisture and suppleness (in a candidate suitable for injectable treatment).
  • Fine lines and superficial wrinkles on and immediately around the lips, including early smoker’s lines.
  • Lips that appear dull, rough or lack healthy sheen and smoothness.
  • Patients with existing lip filler who want to enhance hydration, texture and definition without adding substantial volume.
  • Patients with untreated lips seeking a subtle, natural-looking plump and improved contour rather than dramatic enlargement.
  • Adjunctive treatment as part of a comprehensive peri-oral rejuvenation plan alongside dermal fillers, toxin or skin boosters in surrounding areas.

Composition

  • Non-cross-linked hyaluronic acid (sodium hyaluronate) 22 mg per 1.1 ml syringe (20 mg/ml equivalent concentration).
  • Physiological saline/aqueous carrier solution (water for injection, sodium chloride).
  • Buffering components (e.g. phosphate buffers) and stabilisers as listed in the internal Instructions for Use.
  • No lidocaine indicated in publicly available product listings; anaesthetic, if required, is typically provided topically or separately according to clinic protocol.

Formulation

  • Sterile, clear, non-cross-linked hyaluronic acid solution for intradermal/submucosal lip injection.
  • HA concentration effectively approx. 20 mg/ml (22 mg in 1.1 ml) aimed at hydration and subtle tissue support rather than firm structural fill.
  • Skin-booster style rheology, designed to diffuse evenly through lip tissue for a soft, natural outcome.
  • Single-use, pre-filled syringe intended for professional injectable use only.

Packaging

  • Retail presentation: 1 x 1.1 ml pre-filled sterile syringe of LUMI-PRO Lips – Lip Booster.
  • Syringe presented in a blister tray within a branded outer carton for protection and identification.
  • Packaging typically labelled with product name, volume (1.1 ml), HA content (22 mg non-cross-linked HA), batch/lot number, expiry date, storage instructions and manufacturer/distributor details.
  • Intended strictly for single-patient, single-use; any unused product after a procedure must be discarded in accordance with sharps and clinical waste regulations.

Usage

  • For professional use only; to be injected exclusively by qualified and appropriately trained medical/aesthetic practitioners familiar with lip anatomy and injectable techniques.
  • Intended injection planes include the superficial submucosal and/or very superficial intradermal layers of the lip, depending on technique and desired effect; it is not designed for deep structural augmentation as with cross-linked fillers.
  • Before treatment, conduct a full medical history and lip assessment, confirming suitability for HA boosters and discussing realistic expectations (hydration, subtle plump, improved quality rather than dramatic enlargement).
  • Apply appropriate antiseptic preparation to the lips and perioral area; topical anaesthetic may be used according to clinic protocol and patient tolerance.
  • Use a fine-gauge needle (commonly 30G or similar) or microcannula; typical techniques include linear threading, serial puncture or small micro-deposits along vermilion and lip body, ensuring even distribution.
  • Avoid intravascular injection by aspirating according to clinic protocol where appropriate, injecting slowly and respecting known vascular anatomy of the lips.
  • Treat both upper and lower lip as required, focusing on hydration and contour rather than heavy boluses; adjust volume according to lip size and desired subtlety.
  • Post-procedure, gently mould if necessary without excessive pressure; provide standard lip aftercare advice including avoiding makeup or occlusive products on lips for several hours, no smoking or drinking through straws immediately post-treatment if possible, and avoidance of excessive heat/sauna/steam rooms for 24–48 hours.
  • Advise patients to maintain good general lip care (hydrating balms, SPF lip protection) alongside booster treatments.
  • Treatment is commonly repeated periodically (e.g. 2–3 sessions initially, then maintenance once or twice per year), based on practitioner protocol and patient response.

Contraindications

  • Known hypersensitivity or allergy to hyaluronic acid or any excipient in the formulation.
  • History of severe anaphylactic reactions or multiple severe allergies that make elective injectable treatments high risk.
  • Active infections, cold sores (herpes labialis), cuts, abrasions or inflammatory conditions affecting the lips or perioral area.
  • Uncontrolled systemic disease, immunosuppression or active autoimmune disease where injectable treatments may pose additional risk, unless carefully assessed by an appropriate clinician.
  • Bleeding disorders or concurrent use of anticoagulant/antiplatelet therapy that significantly increases bruising/bleeding risk, unless the risk–benefit is assessed and managed by the prescriber.
  • Pregnancy and breastfeeding, as elective cosmetic injectables are generally avoided due to insufficient safety data.
  • Previous permanent fillers or implants within the lips may require extra caution; use only after specialist assessment to avoid product interactions or irregularities.
  • Any other contraindications, warnings or patient exclusions outlined in the product’s professional Instructions for Use and local clinical guidelines must be observed.

Adverse Effects

  • Common, transient injection-site reactions: redness, swelling, tenderness, bruising, mild pain, itching and small haematomas at injection points.
  • Temporary asymmetry or unevenness due to local swelling or product placement, generally resolving as oedema subsides and product integrates.
  • Small palpable lumps or nodules if product is unevenly distributed; often self-limiting or manageable with gentle massage when appropriate and safe.
  • Less common adverse effects include prolonged oedema, localised infection, significant bruising or inflammatory nodules, which may require clinical management.
  • Rare hypersensitivity reactions to hyaluronic acid or excipients, presenting with persistent swelling, erythema or pruritus; may warrant medical evaluation and potential treatment.
  • Very rare but serious complications can include intravascular injection with vascular compromise and tissue ischaemia; although less likely with non-cross-linked boosters, injectors must remain vigilant and be prepared to follow emergency protocols.
  • Patients should be advised to contact the clinic promptly if they experience severe or worsening pain, blanching or discolouration, progressive swelling, ulceration, signs of infection (heat, redness, pus, fever) or any unexpected symptoms.

Storage Conditions

  • Store in the original carton in a clean, dry environment, protected from direct sunlight and excessive heat.
  • Maintain within the temperature range specified on the packaging (typically 2–25°C or room temperature); do not freeze.
  • Do not use if the blister, syringe or tamper-evident seals appear damaged or compromised.
  • Inspect the solution visually prior to use; do not inject if it appears cloudy, discoloured or contains particulate matter.
  • Do not use after the expiry date printed on the carton and syringe.
  • Store out of reach of children and unauthorised persons, following local regulations for the storage of injectable aesthetic products.

Duration

As a non-cross-linked HA skin booster for lips, LUMI-PRO Lips typically provides visible improvements in hydration, smoothness and subtle volume for several months. Many clinics recommend an initial course (for example, 2\u20133 sessions spaced 4\u20138 weeks apart) followed by maintenance treatments once or twice per year, although exact duration varies with individual metabolism, lifestyle, lip movement and baseline condition.

Onset

Hydration and subtle plumping effects are often visible immediately after injection, with lips appearing smoother, more defined and glossier once initial swelling subsides. Final, settled results are usually appreciated within a few days, as minor injection-site swelling and redness resolve and the HA equilibrates within lip tissue.

Browse more Injectable skin booster

Top Treatments

Top Cities in the UK